Develop Better LNP-Based Genetic Medicines
Credit : Istock
Lipid nanoparticle (LNP)-based genetic medicines are one of the most advanced non-viral genetic drug delivery systems available. However, LNP-related impurities can compromise the integrity and safety of genetic medicine products if they are not effectively characterized and removed.
By gaining a deeper insight into the critical quality attributes (CQAs) of your LNP-based products, its possible to accelerate development of new therapeutics such as vaccines and gene editing technologies.
This content pack contains a variety of webinar and technical note resources to support you in building better genetic medicine products.
Download this content pack to discover:
- Optimized methods for impurity and integrity analysis
- Simple, fast and robust purity testing and degradation monitoring methods
- Better LNP handling methods for superior product quality
Brought to you by
Download this content pack for FREE now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
